8:43AM On The Wires (WIRES) : Ligand Pharmaceuticals (LGND) announced that it has entered into a Captisol license agreement with SAGE Therapeutics for the development and commercialization of Captisol-enabled therapeutics for a broad range of debilitating central nervous system conditions